Enalapril Maleate Tablet
Product Images NDC 0904-7312
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Enalapril Maleate (NDC 0904-7312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 02)
This is a list comparing the incidence of various side effects in patients taking Enatapril versus Placebo. For example, incidences of body as a whole, cardiovascular, digestive, nervous/psychiatric, respiratory, skin, and urogenital side effects are listed along with the number of patients experiencing each side effect.*
Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 03)
This text provides information on the initial dosage of Creatinine based on the renal status and clearance of patients. It indicates different dosage levels for individuals with normal renal function, mild impairment, moderate to severe impairment, and for dialysis patients. The text also emphasizes warnings about anaphylactoid reactions during membrane exposure and mentions the importance of adjusting dosage on nondialysis days based on blood pressure response.*
20mg Carton Label (8fe8dc52 Dee6 4d33 B798 E90128011f46 00)
This text is a label for Enalapril Maleate tablets USP, with each tablet containing 20 mg of enalapril maleate. It provides information on the usual dosage, storage conditions, precautions, and warnings. The tablets are to be stored at a controlled room temperature and protected from moisture. The package is a unit dose intended for institutional use only and should be kept out of reach of children. Additionally, the label includes the NDC number, product information, and details on packaging and distribution by Major Pharmaceuticals.*
10mg Carton Label (8fe8dc52 Dee6 4d33 B798 E90128011f46 01)
This text contains information about Major Enalapril Maleate Tablets USP, each tablet containing 10 mg of enalapril maleate. The usual dosage information is available in the product insert along with precautions and warnings. The tablets are intended for institutional use only and should be kept out of reach of children. A storage temperature range of 20-25°C is recommended and the tablets should be protected from light. The provided NDC code is 0904-7311-61 for the unit dose packaging. Additionally, the text mentions Avet Pharmaceuticals Inc. as the manufacturer.*
5mg Carton Label (8fe8dc52 Dee6 4d33 B798 E90128011f46 02)
This text provides information about Enalapril Maleate Tablets USP in a unit dose pack containing 100 tablets. Each tablet contains 5 mg of enalapril maleate, USP. It advises to store the medication at 20°C to 26°C (68°F to 77°F) and protect from moisture. Dosage instructions and further details are available in the product insert. It mentions to dispense in a tightly closed, light-resistant container as defined by USP standards. The package revision date is 07/24 and the drug product is sourced from NBC 83585-708, Aves Pharmaceuticals.*
2.5mg Carton Label (8fe8dc52 Dee6 4d33 B798 E90128011f46 03)
This is a description for Enalapril Maleate Tablets USP in a unit dose package. Each tablet contains 2.6 mg of enalapril. The usual dosage information can be found in the product insert. It is recommended to store at 20°C to 25°C and protect from moisture. The package is not child-resistant and is intended for institutional use only. It is distributed by Major Pharmaceuticals in Indianapolis, USA.*
Avet-logo (Avet Logo)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.